Patent ID: 8980954
Filing Date: 2015-03-17
Classification: A61K,A61P,C07D

Abstract:
1. A method of treating Alzheimer's disease in a patient in need, the method comprising administering to the patient a composition comprising a therapeutically effective amount of at least one compound selected from the group consisting of (E)-4-Ethoxystilbene (4k), (E)-4-N,N-Dimethylaminostilbene (4cc), (E)-3,4′-Dimethoxystilbene (6r), (E)-4′-Methoxy-3-methylstilbene (6i), (E)-2-Fluoro-4′-methoxystilbene (6p), (E)-3-Fluoro-4′-methoxystilbene (6n), (E)-4-Fluoro-4′-methoxystilbene (6m), (E)-3-Chloro-4′-methoxystilbene (6h) and (E)-4′-Methoxy-4-methylstilbene (6d), or a pharmaceutically acceptable salt, hydrate or solvate thereof, optionally in combination with a pharmaceutically acceptable carrier, additive or excipient.